Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02080
Full Text
Open PDFAbstract
Available in full text
Date
September 11, 2018
Authors
Publisher
Frontiers Media SA